We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Events

09 Apr 2024 - 12 Apr 2024
15 Apr 2024 - 17 Apr 2024
23 Apr 2024 - 26 Apr 2024

Oral Fluid Testing Established for Pertussis

By LabMedica International staff writers
Posted on 19 Jun 2014
Print article
Image: Electron micrograph of the bacterium Bordetella pertussis, the causative agent of pertussis (Photo courtesy of Sanofi Pasteur).
Image: Electron micrograph of the bacterium Bordetella pertussis, the causative agent of pertussis (Photo courtesy of Sanofi Pasteur).
Existing surveillance systems for pertussis or whooping cough are inadequate and tend to be biased toward identifying severe cases in infants, as reflected by extremely high reported incidence for this age group.

Bordetella pertussis, the causative agent of pertussis, has been isolated from the nasopharynx by use of conventional microbiological techniques. However, culture requires that a specimen be collected early in the illness and might lack sensitivity because the organism is delicate, and any delay in processing specimens can reduce the probability of isolation.

Microbiologist at Public Health England (Colindale, London, UK) have introduced a new oral fluid testing service that was pilot tested throughout England and Wales. When a case was reported, if the diagnosis had not been confirmed by culture, polymerase chain reaction (PCR), or serologic testing, oral fluid sampling kits were mailed either directly to the patients or to the parents/guardians of patients, as the kit was suitable for use at home, or to their general practitioner. The sampling kit contained an ORACOL saliva collection swab (Malvern Medical Developments Ltd, Worcester, UK).

Oral fluid was eluted from each swab and tested for immunoglobulin G (IgG) against pertussis toxin by enzyme-linked immunoassay (ELISA). During the oral fluid pilot testing period, 2,756 oral fluid kits were sent, 2,587 clinical cases were reported, and 2,443 cases of pertussis were confirmed by at least one laboratory method. Of these confirmed cases, 751 were confirmed by oral fluid testing plus or minus other methods and 591 (24% of all cases) were confirmed by oral fluid testing only, which increased laboratory ascertainment of pertussis by 32%, and a maximal increase of 124% occurred among children 5 to 9 years of age.

The authors concluded that the introduction of serologic testing followed by oral fluid testing has successively narrowed the gap in surveillance for pertussis in England and Wales. Patients whose pertussis was confirmed by oral fluid testing were least likely to be hospitalized, suggesting that milder community cases were being confirmed by this method. Oral fluid testing is an easily administered, noninvasive surveillance tool that could further our understanding of pertussis epidemiology and thereby contribute to decisions on vaccination strategies. The study was published in the June 2014 issue of the journal Emerging Infectious Diseases.

Related Links:
Public Health England
Malvern Medical Developments Ltd.


Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
HLX
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
New
Gold Member
Systemic Autoimmune Testing Assay
BioPlex 2200 ANA Screen with MDSS

Print article

Channels

Clinical Chemistry

view channel
Image: Reaching speeds up to 6,000 RPM, this centrifuge forms the basis for a new type of inexpensive, POC biomedical test (Photo courtesy of Duke University)

POC Biomedical Test Spins Water Droplet Using Sound Waves for Cancer Detection

Exosomes, tiny cellular bioparticles carrying a specific set of proteins, lipids, and genetic materials, play a crucial role in cell communication and hold promise for non-invasive diagnostics.... Read more

Molecular Diagnostics

view channel
Image: MOF materials efficiently enrich cfDNA and cfRNA in blood through simple operational process (Photo courtesy of Science China Press)

Blood Circulating Nucleic Acid Enrichment Technique Enables Non-Invasive Liver Cancer Diagnosis

The ability to diagnose diseases early can significantly enhance the effectiveness of clinical treatments and improve survival rates. One promising approach for non-invasive early diagnosis is the use... Read more

Hematology

view channel
Image: The low-cost portable device rapidly identifies chemotherapy patients at risk of sepsis (Photo courtesy of 52North Health)

POC Finger-Prick Blood Test Determines Risk of Neutropenic Sepsis in Patients Undergoing Chemotherapy

Neutropenia, a decrease in neutrophils (a type of white blood cell crucial for fighting infections), is a frequent side effect of certain cancer treatments. This condition elevates the risk of infections,... Read more

Pathology

view channel
Image: The OvaCis Rapid Test discriminates benign from malignant epithelial ovarian cysts (Photo courtesy of INEX)

Intra-Operative POC Device Distinguishes Between Benign and Malignant Ovarian Cysts within 15 Minutes

Ovarian cysts represent a significant health issue for women globally, with up to 10% experiencing this condition at some point in their lives. These cysts form when fluid collects within a thin membrane... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.